Isoptin (Verapamil Hydrochloride)

Verapamil blocks L‑type calcium channels on cardiac and vascular smooth‑muscle cells. By reducing calcium entry, it decreases myocardial contractility, dilates arterial vessels, and slows conduction through the atrioventricular node, which together lower blood pressure and control heart‑rate abnormalities.

The specific dose of Isoptin is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Dosage regimens are tailored to each patient and should follow the prescriber’s instructions.

Verapamil should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers evaluate each case individually, and patients should discuss any concerns with their prescriber.

To request Isoptin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Isoptin (verapamil) is a non‑dihydropyridine calcium‑channel blocker, primarily affecting cardiac conduction and contractility, whereas dihydropyridine agents (e.g., amlodipine) mainly cause peripheral vasodilation. Verapamil is therefore preferred when rate control of supraventricular arrhythmias is needed, while other agents are often chosen for pure antihypertensive effects.

Isoptin should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keeping the product within this temperature range preserves its stability and potency.

Isoptin is supplied as an intravenous solution and is administered by a healthcare professional through a controlled IV infusion. The rate and duration of infusion are set by the prescriber according to the clinical indication and patient response.

Serious risks include severe bradycardia, heart block, marked hypotension, and rare cases of myocardial infarction or hepatic dysfunction. Patients should be monitored closely for these events, especially during initiation or dose adjustments.

Isoptin is contraindicated in patients with known hypersensitivity to verapamil or other calcium‑channel blockers, those with severe sinus node dysfunction without a pacemaker, advanced atrioventricular block, or uncontrolled heart failure. Clinicians must assess each patient’s medical history before prescribing.